Conservative Versus Operative Treatment of Displaced Neck Fractures of the Fifth Metacarpal

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00704002

Acronym

CONFraM

Enrollment

Registered

2008-06-24

Start date

2006-12-31

Completion date

2010-06-30

Last updated

2013-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fifth Metacarpal Neck Fracture

Keywords

neck fracture of the fifth metacarpal, displacement, antegrade intramedullary splinting, conservative treatment

Brief summary

This is a prospective, randomized, multi-center pilot study of isolated, displaced neck fractures of the fifth metacarpal. The patients are randomly assigned to osteosynthesis with antegrade intramedullary splinting or conservative treatment.

Detailed description

The aim of this study is to provide criteria for treatment decisions in patients with isolated, displaced neck fractures of the fifth metacarpal. The primary outcome criterion is the functional status measured by the Disability of the Arm, Shoulder and Hand (DASH) questionnaire. Secondary outcome criteria are pain, range of motion (ROM), grip strength, and radiological parameters.

Interventions

PROCEDUREantegrade intramedullary splinting

antegrade intramedullary splinting with 2 to 3 small K-wires

PROCEDUREconservative treatment

conservative treatment with 2-finger splint for one week

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* displaced neck fracture of the fifth metacarpal (at least 30° angulation) * isolated injury * age between 18 and 75 years * informed consent

Exclusion criteria

* rotational displacement * open fracture * injury older than one week * treatment other than within this study * other relevant injuries of the upper extremities * other injury or disease of the hand * pregnancy * missing informed consent * incompliance * coagulopathy * allergy to metallic implants * Patients who have participated in any other device or drug clinical trial within the previous month

Design outcomes

Primary

Measure	Time frame
Disability of the Arm, Shoulder and Hand (DASH) questionnaire	3 months

Secondary

Measure	Time frame
pain	3 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026